Openfund

CORDIS · EATRIS-Plus

Consolidating the capacities of EATRIS-ERIC for Personalised Medicine

Code
EATRIS-Plus
Programme
H2020
Call
INFRADEV-03-2018-2019
Status
CLOSED
Period
2020-01-01 – 2023-12-31
Total cost (whole consortium)4 999 024 €
EU contribution (whole consortium)4 999 023 €
EU contribution to Bulgarian participants65 625 €

Official data · CORDIS · synced 2026-10-17 10:16 · official record

Participants

OrganisationsRoleCountryGrant
EATRIS ERICcoordinatorNL972 508 €
UNIVERZITA PALACKEHO V OLOMOUCIparticipantCZ571 000 €
STICHTING RADBOUD UNIVERSITAIR MEDISCH CENTRUMparticipantNL432 260 €
UPPSALA UNIVERSITETparticipantSE392 362 €
HELSINGIN YLIOPISTOparticipantFI368 761 €
LUXEMBOURG INSTITUTE OF HEALTHparticipantLU313 292 €
SERVICIO MADRILENO DE SALUDparticipantES276 120 €
FORUM DES PATIENTS EUROPEENSparticipantBE195 134 €
UNIVERSITETET I OSLOparticipantNO160 375 €
INFARMED - AUTORIDADE NACIONAL DO MEDICAMENTO E PRODUTOS DA SAUDE IPparticipantPT149 375 €
BIOCAT LA FUNDACIO BIOREGIO DE CATALUNYAparticipantES144 720 €
COMMISSARIAT A L ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVESparticipantFR143 412 €
UNIVERZA V LJUBLJANIparticipantSI137 750 €
ISTITUTO SUPERIORE DI SANITAparticipantIT133 344 €
THE PROVOST, FELLOWS, FOUNDATION SCHOLARS & THE OTHER MEMBERS OF BOARD, OF THE COLLEGE OF THE HOLY & UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLINparticipantIE106 210 €
KLINIKUM DER TECHNISCHEN UNIVERSITÄT MÜNCHEN (TUM KLINIKUM)participantDE101 250 €
RIGAS STRADINA UNIVERSITATEparticipantLV93 438 €
SOFIA UNIVERSITY ST KLIMENT OHRIDSKIparticipantBG65 625 €
SVEUCILISTE U ZAGREBU MEDICINSKI FAKULTETparticipantHR45 394 €
FUNDACIO HOSPITAL UNIVERSITARI VALL D'HEBRON - INSTITUT DE RECERCAparticipantES43 055 €
ITA-SUOMEN YLIOPISTOparticipantFI40 024 €
OSPEDALE SAN RAFFAELE SRLthird partyIT0 €
EUROPEAN AIDS TREATMENT GROUP EVthird partyDE0 €
Masarykova univerzitathird partyCZ0 €

Description

In the first five years of operations, EATRIS has shown strong proof of concept of the value of the services portfolio, with users ranging from academia, SMEs, large pharma, to biotech and research funding organisations. The overarching aim of EATRIS-Plus is to support the long-term sustainability (LTS) of EATRIS by delivering innovative scientific tools to the research community, strengthening the infrastructure’s financial model and reinforcing EATRIS leadership in the European Research Area (ERA), particularly in the field of Personalised Medicine (PM) research and development. Specific objectives are: (i) To consolidate EATRIS capacities in the field of PM to better serve academia and industry and augment the number of EATRIS Innovation Hubs with large pharma; (ii) To further strengthen the LTS of EATRIS financial model; (iii) To drive patient empowerment through active involvement in the infrastructure’s operations; (iv) To expand strategic partnerships with Research Infrastructures and other relevant stakeholders. The proposal relies on a scientific and technological programme combined with capacity-building activities across 16 EU countries, with the support of two umbrella organisations representing patient organisations and SMEs. EATRIS-Plus will help pooling and exploiting the translational academic capacities of the infrastructure in omic technologies to enable researchers to better address the scientific and societal challenge of PM. Additionally, the coordination office and 13 existing national nodes of the infrastructure will participate in implementing joint outreach, training, industry engagement and international collaboration activities to further build national capacity, increase users’ trust and strengthen EATRIS and the ERA global scientific leadership.

Official data · CORDIS · synced 2026-10-17 10:16 · official record · Licence: © European Union, CC BY 4.0 (Commission reuse policy).